Kanto Denka Kogyo Co., Ltd. · TSE:4047

Kanto Denka Kogyo — H1 FY2023 Earnings Presentation

60 slides from Kanto Denka Kogyo's earnings presentation, Nov 22, 2023

  1. Slide 1: Financial Results Briefing for the Six Months Ended September 30, 2023

    Financial Results Briefing for the Six Months Ended September 30, 2023 and Revision of the Medium-Term Management Plan Kanto Denka Kogyo Co., Ltd. (Tokyo Stock Exchange Prime Market, Securities Code: 4047) November 22, 2023

  2. Slide 2: Contents

    Contents I Overview of Financial Results for the Six Months Ended September 30, 2023 II Business Outlook and Future Trends III Supplementary Materials © Kanto Denka Kogyo Co., Ltd. All rights reserved. 2

  3. Slide 3: I Overview of Financial Results for the Six Months Ended September 30, 2023

    I Overview of Financial Results for the Six Months Ended September 30, 2023 © Kanto Denka Kogyo Co., Ltd. All rights reserved. 3

  4. Slide 4: Key Earnings Data

    Key Earnings Data  Rapid deterioration in the fine chemicals business environment Fluorochemicals for semiconductors: Impacted by production cuts due to inventory adjustments by semiconductor manufacturers Battery materials: Deterioration in supply and demand environment due to slowing growth in th

  5. Slide 5: Statement of Income

    Statement of Income (Billions of yen) H1 FY2022 H1 FY2023 Difference % change Net sales 37.3 34.8 –2.4 –6.6 Operating profit 6.5 (0.4) –7.0 — Ordinary profit 7.3 0.1 –7.2 –98.1 Profit before income taxes 7.1 0.4 –6.7 –93.5 Profit attributable to owners of parent 5.1 0.2 –4.9 –95.0 Basic earnings per

  6. Slide 6: Balance Sheet

    Balance Sheet (Billions of yen) FY2022 H1 FY2023 Difference % change Assets 130.7 124.4 –6.2 –4.8 Cash and deposits 22.3 21.4 –0.8 –3.8 Trade receivables 21.6 17.4 –4.2 –19.8 Inventories 23.9 21.0 –2.8 –12.0 Non-current assets (tangible + intangible) 48.0 50.8 2.7 5.7 Liabilities 61.9 54.9 –7.0 –11.

  7. Slide 7: Fundamental Chemicals Division

    Fundamental Chemicals Division (Billions of yen) H1 FY2022 H1 FY2023 Difference Net sales 4.1 4.3 0.2 Operating profit (loss) 0.0 (0.0) –0.0 Net sales ・ Caustic soda: Sales increased due to effects from price revisions, despite lower sales volumes ・ Hydrochloric acid: Sales decreased due to lower sa

  8. Slide 8: Fine Chemicals Division

    Fine Chemicals Division (Billions of yen) H1 FY2022 H1 FY2023 Difference Net sales 30.3 28.2 –2.1 Operating profit (loss) 6.0 (0.8) –6.8 Net sales ・ Nitrogen trifluoride: Sales decreased due to lower sales volume ・ Tungsten hexafluoride: Sales decreased due to lower sales volume ・ Hexafluoro-1,3-but

  9. Slide 9: Ferrochemicals, Commercial Business, Facilities Divisions

    Ferrochemicals, Commercial Business, Facilities Divisions (Including consolidation adjustments) (Billions of yen) H1 FY2022 H1 FY2023 Difference Net sales 2.8 2.2 –0.6 Operating profit 0.4 0.4 –0.0 Ferrochemicals Sales decreased due to lower sales volume of carriers Commercial Business Unchanged yea

  10. Slide 10: Consolidated Operating Profit: Difference Analysis (H1 FY2022 vs. H1 FY2023)

    Consolidated Operating Profit: Difference Analysis (H1 FY2022 vs. H1 FY2023) (Billions of yen) 808 The price of lithium declined substantially from 606 the end of last fiscal year. An impairment loss –2.53 was recognized on inventories of high-priced 404 lithium compounds. 6.58 –1.46 202 –0.72 –2.75

  11. Slide 11: Operating Profit and Operating Profit Margin Over Time

    Operating Profit and Operating Profit Margin Over Time (Consolidated) (Billions of yen) 17.9% 20% 17.1% 16.5% Operating profit 140 14 14.4% 15% Operating profit margin 110 11 10.9% 10% 80 8 12.9 11.1 5% 5 50 9.4 7.7 –1.2% 2 20 5.6 0% –0.4 –1 -10 -5% FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 (through

  12. Slide 12: Capital Investment and Depreciation Over Time

    Capital Investment and Depreciation Over Time (Consolidated) (Billions of yen) 20 200 Capital investment 16 160 Depreciation 12 120 H2 plan 9.7 8 80 16.6 H2 plan 12.2 4.9 10.2 10.1 4 40 8.4 6.7 7.6 5.0 5.4 6.6 5.8 4.0 0 Investment Depreciation Investment Depreciation Investment Depreciation Investme

  13. Slide 13: The Kanto Denka Group (Consolidated Subsidiaries)

    The Kanto Denka Group (Consolidated Subsidiaries) (Billions of yen) Share of Net sales: Year-on-year Capital Major business lines investment (%) H1 FY2023 change Sale of chemical products, maintenance Kanden Kosan Co., Ltd. ¥10 mil. 100.0 4.8 –0.0 of containers, insurance agency services Manufacture

  14. Slide 14: II Business Outlook and Future Trends

    II Business Outlook and Future Trends © Kanto Denka Kogyo Co., Ltd. All rights reserved. 14

  15. Slide 15: Performance Forecast By Segment (Consolidated)

    Performance Forecast By Segment (Consolidated) (Billions of yen) Net sales Operating profit FY2023 FY2023 FY2023 FY2023 FY2022 (results) FY2022 (results) (initial forecast) (revised forecast) (initial forecast) (revised forecast) Fundamental 9.4 9.7 9.2 0.3 0.3 0.3 Chemicals Fine Chemicals 63.9 62.7

  16. Slide 16: Performance Forecast By Segment: H1 Forecast vs. Results

    Performance Forecast By Segment (Consolidated): H1 Forecast vs. Results (Billions of yen) Net sales Operating profit H1 (forecast) H1 (results) Difference H1 (forecast) H1 (results) Difference Fundamental Chemicals 4.5 4.3 –0.1 (0.1) (0.0) 0.0 Fine Chemicals 28.9 28.2 –0.6 1.2 (0.8) –2.0 Other* 2.9

  17. Slide 17: Consolidated Operating Profit: Difference Analysis (H1 Forecast vs. Results)

    Consolidated Operating Profit: Difference Analysis (H1 Initial Forecast vs. H1 Results) (Billions of yen) 20 2 The price of lithium was lower than the initial forecast. 10 1 The impairment loss on inventories increased for lithium 1.50 –1.56 compounds. 0 –0.01 +0.20 –0.64 –0.42 +0.09 –1 -10 Sales/pr

  18. Slide 18: Performance Forecast By Segment: H1 vs. H2

    Performance Forecast By Segment (Consolidated): H1 vs. H2 (Billions of yen) Net sales Operating profit H1 (results) H2 (forecast) Difference H1 (results) H2 (forecast) Difference Fundamental Chemicals 4.3 4.8 0.4 (0.0) 0.3 0.3 Fine Chemicals 28.2 21.7 –6.4 (0.8) (2.2) –1.3 Other* 2.2 2.3 0.1 0.4 0.3

  19. Slide 19: Consolidated Operating Profit: Difference Analysis (H1 Result vs. H2 Forecast)

    Consolidated Operating Profit: Difference Analysis (H1 Result vs. H2 Forecast) (Billions of yen) Mainly from: 2 20 Full impairment loss Decrease in subsidiary profits: –¥1.20 billion recognized in H1 Increase in fixed costs: –¥1.02 billion 10 1 00 –0.42 –2.46 +3.32 -10 –1.50 –1 –1.88 -20 –2 +0.82 –0

  20. Slide 20: Topics (Status of Major Capital Investments)

    Topics (Status of Major Capital Investments) Investment Details Remarks Hexafluoro-1,3-butadiene (C4F6) 400 t/yr ⇒ 600 t/yr ・Scheduled to commence operation in FY2024 Carbonyl sulfide (COS) 150 t/yr ⇒ 200 t/yr ・Scheduled to commence operation in FY2025 Lithium hexafluorophosphate 5,400 t/yr ⇒ 8,000

  21. Slide 21: III Supplementary Materials

    III Supplementary Materials © Kanto Denka Kogyo Co., Ltd. All rights reserved. 21

  22. Slide 22: Outlook for Major Products: Nitrogen Trifluoride (NF3)

    -Outlook for Major Products- Nitrogen Trifluoride (NF3)  Chamber cleaning gas for plasma CVD equipment for semiconductor and FPD manufacturing  Production capacity: 3,700 t/yr. Demand trends (Kanto Denka forecasts for Forecasted market share tons FY2023 and beyond) 50,000 ・Kanto Denka holds over 1

  23. Slide 23: Outlook for Major Products: Tungsten Hexafluoride (WF6)

    -Outlook for Major Products- Tungsten Hexafluoride (WF6)  Wiring material gas for semiconductors  Production capacity: 720 t/yr. (Nov. 2016) ➡ 910 t/yr. (Aug. 2018) ➡ 1,400 t/yr. (Oct. 2019) Demand trends (Kanto Denka forecasts for tons FY2023 and beyond) Forecasted market share 8,000 ・ Kanto Denk

  24. Slide 24: Outlook for Major Products: Hexafluoro-1,3-butadiene (C4F6)

    -Outlook for Major Products- Hexafluoro-1,3-butadiene (C4F6)  Etching gas for semiconductors  Production capacity: 260 t/yr. (Dec. 2019) ➡ 400 t/yr. (Apr. 2022) ➡ 600 t/yr. (Scheduled to commence operation in FY2024) Demand trends (Kanto Denka forecasts for tons FY2023 and beyond) Forecasted marke

  25. Slide 25: Outlook for Major Products: Carbonyl Sulfide (COS)

    -Outlook for Major Products- Carbonyl Sulfide (COS)  Etching gas for semiconductors  Production capacity: 80 t/yr. (Oct. 2019) ➡ 150 t/yr. (June 2022) ➡ 200 t/yr. (Scheduled to commence operation in FY2025) Demand trends (Kanto Denka forecasts for tons FY2023 and beyond) Forecasted market share 50

  26. Slide 26: Outlook for Major Products: Lithium Hexafluorophosphate (LiPF6)

    -Outlook for Major Products- Lithium Hexafluorophosphate (LiPF6)  Electrolyte materials for lithium-ion secondary batteries  Demand reaches full-scale pace for EVs and other in-vehicle applications  Production capacity: 5,400 t/yr. ➡ 8,000 t/yr. (Scheduled to commence operation in FY2024) Demand

  27. Slide 27: Overseas Production Sites: Kanto Denka Fine Products Korea

    -Overseas Production Sites- Kanto Denka Fine Products Korea Co., Ltd.  Location Cheonan City, South Chungcheong Province, Republic of Korea  Business Lines Manufacture and sale of fluorochemicals for semiconductors and FPDs  Production Items ・ Carbonyl sulfide (COS) ・ Carbon tetrafluoride (CF4) ・

  28. Slide 28: Overseas Production Sites: Xuancheng KDK Technology

    -Overseas Production Sites- Xuancheng KDK Technology Co., Ltd.  Location Xuancheng City, Anhui Province, People's Republic of China  Business Lines Manufacture and sale of fluorochemicals for semiconductors Approx. 250 km and FPDs  Production Items Phase I construction: ・ Ammonium fluoride Phase

  29. Slide 29: Kanto Denka's Technology and Business Direction

    Kanto Denka's Technology and Business Direction ■Future SDGs/ESG High-sensitivity LIB materials using Significantly strengthen existing analysis recycled Li businesses Create new business pillars Fine Chemicals Fluorination High purity Fluorochemicals MI* and Battery materials computational science

  30. Slide 30: Business Segments

    Business Segments Name Products and services Inorganic products Caustic soda, hydrochloric acid, sodium hypochlorite, aluminum chloride, etc. Fundamental Chemicals Organic products Trichloroethylene, perchloroethylene, vinylidene chloride, cyclohexanol, etc. Sulfur hexafluoride, carbon tetrafluoride

  31. Slide 31: Notes

    Notes  This document does not constitute disclosure material as defined by the Financial Instruments and Exchange Act and other laws and regulations, and therefore the Company does not guarantee its accuracy or completeness.  Performance forecasts in this document were created based on information

  32. Slide 32: Revision of the 12th Medium-Term Management Plan

    Revision of the 12th Medium-Term Management Plan November 22, 2023 Kanto Denka Kogyo Co., Ltd. Jun’ichi Hasegawa, President 32

  33. Slide 33: Contents

    Contents © Kanto Denka Kogyo Co., Ltd. All rights reserved. 33

  34. Slide 34: Progress on the 12th Medium-Term Management Plan

    Progress on the 12th Medium-Term Management Plan © Kanto Denka Kogyo Co., Ltd. All rights reserved. 34

  35. Slide 35: Progress on the 12th Medium-Term Management Plan (Numerical Targets)

    Progress on the 12th Medium-Term Management Plan (Numerical Targets) (Billions of yen) FY2023 Consolidated basis FY2022 plan FY2022 results FY2023 plan announced Oct. 25 Net sales 76.0 78.6 92.0 63.8 11th Medium-Term Management Plan (Consolidated) Operating profit 10.9 12.9 13.0 –2.0 Operating profi

  36. Slide 36: Progress on 12th Medium-Term Management Plan (Key Strategies)

    Progress on 12th Medium-Term Management Plan (Key Strategies) Key Strategies 〇: Achievements ▲: Challenges 〇 Increased COS capacity (Jun. 2022) Promote ✓ Capacity expansion to address market growth expansion of the 〇 Brought KSG-14 (low GWP gas) to market (Apr. (semiconductor gases and battery mater

  37. Slide 37: Revision of the 12th Medium-Term Management Plan

    Revision of the 12th Medium- Term Management Plan © Kanto Denka Kogyo Co., Ltd. All rights reserved. 37

  38. Slide 38: Assumptions at the time the Medium-Term Management Plan was formulated

    Background on Revision Assumptions at the time the Medium-Term Management Plan was formulated  Expansion of semiconductor and EV markets Growth through active  Demands for supply from investment plans customers Change in performance over time Change in business environment  Ascertaining the cost

  39. Slide 39: Policy on Revision

    Policy on Revision  Temper our strengths and implement measures to accelerate growth further  Steadily capture medium and long-term market growth Innovative development-  Business strategy  Increasing capital driven company efficiency  Strengthening governance  Human capital strategy Our visio

  40. Slide 40: Measures to Increase Corporate Value Considering Capital Costs

    Business strategy Measures to Increase Corporate Value Considering Capital Costs Growth Inefficient Fine businesses Direction of Each Segment businesses Chemicals Fine Chemicals (fluorochemicals) (battery materials) Fine  Concentrate investment in development of and Chemicals investment in growth p

  41. Slide 41: Business Strategy - Growth Strategy (Fluorochemicals)

    Business Strategy -Growth Strategy (Fluorochemicals)- Our strengths Mission  World-class fluorination Use technologies that are cutting Opportunities technology edge on a global stage to supply  Height of market  Extensive experience and track the specialty materials needed growth potential recor

  42. Slide 42: Business Strategy - Growth Strategy (Battery Materials)

    Business Strategy -Growth Strategy (Battery Materials)- Opportunities Mission Our strengths  Rapid market growth Use technologies that are cutting  Expectations of our  Top quality in the industry edge on a global stage to supply products and  Extensive expertise and the specialty materials need

  43. Slide 43: Business Strategy - Portfolio Transformation

    Business Strategy -Portfolio Transformation (Ferrochemicals and Fundamental Chemicals)- Challenges in Challenges in Fundamental Ferrochemicals Chemicals  Market shrinkage due to going  Market shrinkage paperless and other trends  Low profitability  Extremely high-mix, low-volume  Increasing cos

  44. Slide 44: Business Strategy - R&D

    Business Strategy - R&D - Early creation of new products leveraging our Theme core technologies Image of the new R&D building  Promoting customer-oriented R&D Strategy  Strengthening the connection between the R&D and Manufacturing functions  Launch R&D operations within the manufacturing site in

  45. Slide 45: Increasing Capital Efficiency - ROIC Tree

    Increasing Capital Efficiency -ROIC Tree-  Add ROIC to the management indicators and aim for a structure that will sustainably generate returns that exceed the weighted average cost of capital (WACC) Specific Initiatives Strengthen Steadily expand sales opportunities by staying earning power close

  46. Slide 46: Increasing Capital Efficiency and Strengthening Governance

    Increasing Capital Efficiency and Strengthening Governance Challenges Increase capital efficiency Reduce cross- shareholdings  Sell around 20% of cross-shareholdings by FY2024 and around another 10% by FY2026 Measures for a cumulative reduction of around 30%  Reduce cross-shareholdings from around

  47. Slide 47: Human capital strategy

    Human capital strategy Human resource development linked Strategy to business strategy Human resource development  Established a new Human Resource Development Department (Jun. 2023) Measures  Plan to introduce a new human resource training program (general and selective) from FY2024 Non-financial

  48. Slide 48: Organizational strategy

    Organizational strategy Strategy Strategic and effective IR activities Strengthen IR  Established a new Public Relations & Investor Measures Relations Department (Jun. 2023)  Publish an Integrated Report (during FY2023) Improve productivity through the use Strategy of digital technology Promote DX

  49. Slide 49: Revision of Numerical Targets

    Revision of Numerical Targets (Billions of yen) Consolidated basis FY2026 Plan Current FY2024 Target Net sales 100.0 100.0 Operating profit 15.0 15.0 Operating profit margin 15.0% 15.0% Equity ratio — 50.0% or more ROE 12.0% or more 12.0% or more ROIC 8.0% or more —  Extended final fiscal year by t

  50. Slide 50: Revision of Numerical Targets (Five Years)

    Revision of Numerical Targets (Five Years) (Billions of yen) Consolidated FY2022 FY2023 FY2024 Before basis revision Net sales 76.0 92.0 100.0 (three years) Operating 10.9 13.0 15.0 profit Extended final fiscal year by two years Consolidated FY2022 FY2023 FY2024 FY2025 FY2026 basis (results) (foreca

  51. Slide 51: Investment Plan (Five Years)

    Investment Plan (Five Years)  We revised the investment plan and timeframe to respond to changes in customer trends and the market environment  Each business division will invest with an awareness of the capital costs  We will continue to invest in growth businesses Other Other ¥5 billion ¥11 bil

  52. Slide 52: View on Allocation of Funds

    View on Allocation of Funds Dividend policy View on shareholder return (Current) Consolidated dividend payout Implement investment plans with an awareness of the ratio of 20% capital costs and undertake a growth strategy and portfolio ⇓ transformation to increase corporate value. Provide (Revised) C

  53. Slide 53: Measures to correct a PBR of less than 1x

    Measures to correct a PBR of less than 1x © Kanto Denka Kogyo Co., Ltd. All rights reserved. 53

  54. Slide 54: Analysis of Current Conditions

    Analysis of Current Conditions ROE (%) Over Time PBR (x) Over Time 20% 2.00 1.00 10% 0.00 0% Mar. 2018 Mar. 2019 Mar. 2020 Mar. 2021 Mar. 2022 Mar. 2023 Mar. 2018 Mar. 2019 Mar. 2020 Mar. 2021 Mar. 2022 Mar. 2023 Kanto Denka Average for other companies in the chemical industry (based on internal res

  55. Slide 55: Measures to correct a PBR of less than 1x

    Measures to correct a PBR of less than 1x Target 1x or higher PBR (currently around 0.7x) ROE PER Strengthen ongoing Expand business, mainly dialog with and in Fine Chemicals communication of information to investors Pursue management × Reduce capital costs by reducing cross- leveraging ROIC shareho

  56. Slide 56: Initiatives for Carbon Neutrality

    Initiatives for Carbon Neutrality © Kanto Denka Kogyo Co., Ltd. All rights reserved. 56

  57. Slide 57: Initiatives for Carbon Neutrality

    Initiatives for Carbon Neutrality Accelerate growth by pursuing further expansion of the fine chemicals Vision for business while also reducing greenhouse gas emissions and pursuing development 2030 of technology aimed at decarbonization to grow into an innovative, development- driven company that c

  58. Slide 58: CO2 Reduction Roadmap

    Initiatives for Carbon Neutrality CO2 Reduction Roadmap Reduction target Targeting carbon neutrality 2030 50% reduction vs. FY2013 2050 (virtually zero emissions) Expansion of production capacity Purchasing non- fossil certificate Portfolio and generating transformation power from Scope 1 and shift

  59. Slide 59: CO2 Emissions from Energy Use Over Time and Reduction Targets

    CO2 Emissions from Energy Use Over Time and Reduction Targets (Scope 1 + Scope 2) Reduction target Targeting carbon neutrality 2030 50% reduction vs. FY2013 2050 (virtually zero emissions) Performance to 2022 vs. FY2013 11% reduction 25.0 CO2 emissions from energy use (10,000 tons) 0.8 20.0 1.1 vs.

  60. Slide 60: Notes

    Notes  This document does not constitute disclosure material as defined by the Financial Instruments and Exchange Act and other laws and regulations, and therefore the Company does not guarantee its accuracy or completeness.  The forecasted numbers in this document were created based on informatio

Kanto Denka Kogyo — H1 FY2023 Earnings Presentation on 6ix